BASF Sets Mid-2027 Target for Agribusiness Listing as Demerger Gathers Pace

BASF confirms Agricultural Solutions IPO readiness for mid-2027, with carve-out nearly done in Americas and Europe. Buyback and raised guidance support shares.

The chemicals giant is quietly assembling the pieces of what could become one of Frankfurt's more closely watched listings in years. BASF has confirmed that its Agricultural Solutions division is on track to be ready for the stock exchange by the middle of 2027, with the carve-out already largely completed in the Americas and Europe and Asia expected to follow by year-end.

Board member Livio Tedeschi, speaking on Tuesday, offered the clearest timetable yet for the separation, though he stopped short of naming a specific date for the debut. The Frankfurt exchange has been earmarked as the venue. For a company that has spent months paring back its sprawling portfolio, the planned IPO represents the most tangible milestone yet in a broader strategic reset that investors have been watching with a mixture of patience and expectation.

That reset has already produced meaningful results. In late June, BASF closed the sale of its Coatings business to private equity firm Carlyle, booking a pre-tax gain of €3.9 billion. The Agricultural Solutions spin-off follows the same logic: rather than clinging to broad diversification, the Ludwigshafen-based group is reshaping itself into a collection of focused, independently viable units.

A Research Push to Match the Corporate Surgery

The organisational separation is being matched by operational investment. At the company's agricultural hub in Limburgerhof, construction is underway on a new Climate Center, backed by a low double-digit million-euro outlay. Completion is slated for the first half of 2027 — timing that dovetails neatly with the IPO preparation schedule. The message to the market is clear: BASF wants the division to stand on its own feet operationally, not just administratively, before it faces public investors.

In North America, the company has also rolled out the second generation of its xarvio CONNECT digital solution, a portable device designed to enable secure data exchange between the xarvio FIELD MANAGER platform and agricultural machinery. Beyond the agribusiness, BASF has opened a performance lab in Mumbai focused on diapers and superabsorbents, offering technical and application services to customers worldwide. The steady drumbeat of project announcements suggests the group is tending to operational detail even as it executes on the big-picture restructuring.

Logistics: The Other Front

The transformation extends beyond the agribusiness. At the Ludwigshafen site, one of Europe's largest road-rail transshipment hubs, the federal government has committed €51 million in funding toward modernising the combined transport terminal. The project, launched jointly by Transport Minister Steffen Bilger and CEO Markus Kamieth, handles more than 1,000 loading units daily. The timing is no coincidence: persistent low-water problems on the Rhine have forced BASF to lean more heavily on alternative transport routes, making the terminal upgrade a strategic priority rather than a routine infrastructure refresh.

What the Market Makes of It All

Investor enthusiasm has been measured rather than exuberant. The shares were trading at €52.17 on Friday, up 1.5 percent on the day, and sitting comfortably above the 200-day average of €48.68. That leaves the stock about 5.2 percent shy of its 52-week high of €55.05, reached in mid-April. Year-to-date, the shares have gained roughly 16 percent, a sign that the restructuring narrative is finding buyers even if daily moves remain choppy — Thursday's session, for instance, saw a 1.1 percent dip.

Providing a further floor under the share price is an ongoing buyback programme. A repurchase of up to €1 billion has been running since Thursday, part of a broader €4 billion scheme announced in September 2024 and scheduled to run through the end of 2028. Between November 2025 and June 2026, BASF had already bought back shares worth around €1.5 billion; roughly 31.6 million shares — about 3.5 percent of share capital — are earmarked for cancellation.

The company's raised full-year guidance, which projects EBITDA before special items of €6.9 billion to €7.7 billion, rounds out a picture of a group simultaneously streamlining its portfolio, returning capital to shareholders and pushing forward with innovation projects.

For the months ahead, the key variables are execution speed — particularly completing the Asian carve-out — and whether the mid-2027 IPO timetable holds. Until then, the buyback remains the most tangible support for the share price, while the prospective listing carries the strategic bet that a separately listed agribusiness will unlock valuation upside that the conglomerate structure has long suppressed.